Expression of costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD40L/B7-1 monoclonal antibodies

Circulation Research

Volumn 83, Issue 4, 1998, Pages 463-469

  Seko, Yoshinori ^a,b,d   Takahashi, Naoyuki ^a   Azuma, Miyuki ^c   Yagita, Hideo ^a   Okumura, Ko ^a   Yazaki, Yoshio ^e  

^a JUNTENDO UNIVERSITY   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NONE

Author keywords

Cardiomyopathy; Immunohistochemistry; Immunology; Myocarditis; Polymerase chain reaction

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY B7 1; RM 80; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; CYTOKINE PRODUCTION; IMMUNOTHERAPY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS MYOCARDITIS;

EID: 0032563679     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.4.463     Document Type: Article

References (38)

1. Woodruff JF. Viral myocarditis: a review. Am J Pathol. 1980,101: 427-484.
2. Seko Y, Tsuchimochi H, Nakamura T, Okumura K, Naito S, Imataka K, Fujii J, Takaku F, Yazaki Y. Expression of major histocompatibility complex class I antigen in murine ventricular myocytes infected with coxsackievirus B3. Circ Res. 1990;69:360-367.
3. Seko Y, Shinkai Y, Kawasaki A, Yagita H, Okumura K, Takaku F, Yazaki Y. Expression of perform in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation. 1991;84: 788-795.
4. Seko Y, Matsuda H, Kato K, Hashimoto Y, Yagita H, Okumura K, Yazaki Y. Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by Coxsackievirus B3. J Clin Invest. 1993;91:1327-1336.
5. Zee-Cheng CS, Tsai CC, Palmer DC, Codd JE, Pennington DG, Williams GA. High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy. J Am Coll Cardiol. 1984;3: 63-70.
6. Parrillo JE, Aretz HT, Palacios I, Fallon JT, Block PC. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation. 1984;69:93-101.
7. Deguchi H, Kitaura Y, Hayashi T, Kotaka M, Kawamura K. Cell-mediated immune cardiocyte injury in viral myocarditis of mice and patients. Jpn Circ J. 1989;53:61-77.
8. Seko Y, Yagita H, Okumura K, Yazaki Y. T-cell receptor Vβ gene expression in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation. 1994;89:2170-2175.
9. Seko Y, Enokawa Y, Yagita H, Okumura K, Yazaki Y. Restricted usage of T-cell receptor Vα genes in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. J Pathol. 1996;178. 330-334.
10. Seko Y, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, Kagawa N, Osada K, Suzuki S, Yagita H, Okumura K, Yazaki Y. Restricted usage of T-cell receptor Vα-Vβ genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. J Clin Invest. 1995; 96:1035-1041.
11. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol. 1989;7:445-480.
12. Yokochi T, Holly RD, Clark EA. Lymphoblastoid antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid lines, and Burkitt's lymphomas. J Immunol. 1982;128:823-827.
13. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol. 1989;143:2714-2722.
14. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 1993;366:76-79.
15. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science. 1993;262:905-907.
16. Seko Y, Takahashi N, Azuma M, Yagita H, Okumura K, Yazaki, Y. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on murine acute myocarditis caused by coxsackievirus B3. Circ Res. 1998;82:613-618.
17. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van-Kooten C, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 1994;180:1263-1272.
18. Ranheim EA, Kipps TJ. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med. 1993;177:925-935.
19. Kelsall BL, Stuber E, Neurath M, Strober W. Interleukin-12 production by dendritic cells: the role of CD40-CD40L interactions in Th1 T-cell responses. Ann N Y Acad Sci. 1996;795:116-126.
20. Nakajima A, Azuma M, Kodera S, Nuriya S, Terash, A, Abe M, Hirose S, Shirai T, Yagita H, Okumura K. Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule. Eur J Immunol. 1995;25:3060-3069.
21. Yazaki Y, Tsuchimochi H, Kuro-o M, Kurabayashi M, Isobe M, Ueda S, Nagai R, Takaku F. Distribution of myosin isozymes in human atrial and ventricular myocardium: comparison in normal and overloaded heart. Eur Heart J. 1984;5(suppl F):103-110.
22. Freudenthal PS, Steinman RM. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci U S A. 1990;87:7698-7702.
23. Seko Y, Takahashi N, Yagita H, Okumura K, Yazaki Y. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3. J Pathol. 1997;183:105-108.
24. Younker K, Smith CW, Anderson DC, Miller D, Michael LH, Rossen RD, Entman ML. Neutrophil adherence to isolated adult cardiac myocytes: induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest. 1992;89:602-609.
25. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation. 1995; 92:1866-1875.
26. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-173.
27. + T cells. Annu Rev Immunol. 1994;12:635-673.
28. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 1995;80:707-718.
29. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway CA Jr, Flavell RA. Requirement for CD40 ligand in costimulation induction. T cell activation, and experimental allergic encephalomyelitis. Science. 1996;273:1864-1867.
30. Mohan C, Shi Y, Laman JD, Datta SK. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol. 1995;154:1470-1480.
31. Dune FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science. 1993;261:1328-1330.
32. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996;381:434-438.
33. Durie FH, Aruffo A, Ledbetter J, Crassi KM, Green WR, Fast LD, Noelle RJ. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest. 1994;94: 1333-1338.
34. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87:1620-1624.
35. Chen L, Ashe A, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 1992;71:1093-1102.
36. + T cells by B7-transfected melanoma cells. Science. 1993;259: 368-370.
37. Geldhof AB, Raes G, Bakkus M, Devos S, Thielemans K, Baetselier PD. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res. 1995;55: 2730-2733.
38. Chambers BJ, Salcedo M, Ljunggren HG. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity. 1996;5: 311-317.